Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 19531 AL 19545

Consideration of the ischaemic basis and treatment of Alzheimer's disease

Pluta R, Ułamek M, Jabłoński M.

Folia Neuropathol. 2010;48(1):11-26.

Immune-inflammatory responses and oxidative stress in Alzheimer's disease: therapeutic implications

Di Bona D, Scapagnini G, Candore G, Castiglia L, Colonna-Romano G, Duro G, Nuzzo D, Iemolo F, Lio D, Pellicanò M, Scafidi V, Caruso C, Vasto S.

Curr Pharm Des. 2010;16(6):684-91. doi: 10.2174/138161210790883769.

Simple choline esters as potential anti-Alzheimer agents

Alcaro S, Arcone R, Costa G, De Vita D, Iannone M, Ortuso F, Procopio A, Pasceri R, Rotiroti D, Scipione L.

Curr Pharm Des. 2010;16(6):692-7. doi: 10.2174/138161210790883796.

Immunotherapy for Alzheimer's disease

Solomon B, Frenkel D.

Neuropharmacology. 2010 Sep-Oct;59(4-5):303-9. doi: 10.1016/j.neuropharm.2010.04.004. Epub 2010 Apr 11.

Current status on Alzheimer disease molecular genetics: from past, to present, to future

Bettens K, Sleegers K, Van Broeckhoven C.

Hum Mol Genet. 2010 Apr 15;19(R1):R4-R11. doi: 10.1093/hmg/ddq142. Epub 2010 Apr 13.

Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process

De Strooper B.

Physiol Rev. 2010 Apr;90(2):465-94. doi: 10.1152/physrev.00023.2009.

Oxidative stress in Alzheimer disease: a possibility for prevention

Bonda DJ, Wang X, Perry G, Nunomura A, Tabaton M, Zhu X, Smith MA.

Neuropharmacology. 2010 Sep-Oct;59(4-5):290-4. doi: 10.1016/j.neuropharm.2010.04.005. Epub 2010 Apr 13.

Aneuploidy and adult neurogenesis in Alzheimer's disease: therapeutic strategies

Taupin P.

Drug Discov Today. 2010 Dec;15(23-24):983-4. doi: 10.1016/j.drudis.2010.04.001. Epub 2010 Apr 13.

Omega-3 fatty acids: potential role in the management of early Alzheimer's disease

Jicha GA, Markesbery WR.

Clin Interv Aging. 2010 Apr 7;5:45-61. doi: 10.2147/cia.s5231.

L-methylfolate, methylcobalamin, and N-acetylcysteine in the treatment of Alzheimer's disease-related cognitive decline

McCaddon A, Hudson PR.

CNS Spectr. 2010 Jan;15(1 Suppl 1):2-5; discussion 6. doi: 10.1017/s1092852900027589.

Anticholinesterase duration in the Australian veteran population

Gadzhanova S, Roughead L, Mackson J.

Aust N Z J Psychiatry. 2010 May;44(5):469-74. doi: 10.3109/00048670903555104.

ACAT inhibition and amyloid beta reduction

Bhattacharyya R, Kovacs DM.

Biochim Biophys Acta. 2010 Aug;1801(8):960-5. doi: 10.1016/j.bbalip.2010.04.003. Epub 2010 Apr 14.

Detection of increased scyllo-inositol in brain with magnetic resonance spectroscopy after dietary supplementation in Alzheimer's disease mouse models

Choi JK, Carreras I, Dedeoglu A, Jenkins BG.

Neuropharmacology. 2010 Sep-Oct;59(4-5):353-7. doi: 10.1016/j.neuropharm.2010.03.011. Epub 2010 Apr 22.

Phospholipase D in brain function and Alzheimer's disease

Oliveira TG, Di Paolo G.

Biochim Biophys Acta. 2010 Aug;1801(8):799-805. doi: 10.1016/j.bbalip.2010.04.004. Epub 2010 Apr 23.

Polymorphism in Alzheimer Abeta amyloid organization reflects conformational selection in a rugged energy landscape

Miller Y, Ma B, Nussinov R.

Chem Rev. 2010 Aug 11;110(8):4820-38. doi: 10.1021/cr900377t.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias